Mr. Olesen has over twenty years of life science intellectual property law experience and is responsible for all intellectual property efforts at eGenesis.
Most recently, he was Senior IP Counsel at the Broad Institute, where he oversaw the filing and prosecution of patents on inventions arising from Broad Institute members and scholars from MIT and Harvard. Prior to joining the Broad, he served as VP of IP and Legal Affairs at Voyager Therapeutics, a gene therapy biotechnology company, and Assistant General Counsel at GlaxoSmithKline, where he managed both pharmaceutical and vaccine patent portfolios.
Prior to his in-house attorney experience, Mr. Olesen spent more than a decade performing patent prosecution and litigation for biotechnology and pharmaceutical clients at the law firms Foley Hoag, WilmerHale, and Finnegan.
Mr. Olesen received his B.S., summa cum laude, from the University of Wisconsin, his J.D., magna cum laude, from Suffolk Law School, and his Ph.D. in Biochemistry from the Massachusetts Institute of Technology. Following his graduate degree, he was a Jane Coffin Childs and Lucile Markey postdoctoral fellow at Harvard University, where he continues to serve on the Board of Tutors in the Biochemical Sciences.